Anheuser-Busch InBev (AB InBev) has released its financial results for the second quarter of 2025. The company provided access to its detailed earnings report, available for download on its website.
AB InBev releases financial results for second quarter of 2025
Michel Doukeris CEO - Anheuser-Busch InBev SA/NV
0Comments
Join the Forum Discussion:
BusinessRelated
Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness
Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…
Volvo announces updated share and vote count after series conversion
The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.
Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria
Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…